← All episodes

AI is Tanking the Stock Market. Why?

| 2 products mentioned
Watch on YouTube ai disruption stock market valuation multiples risk pricing artificial intelligence equity markets business model disruption

The All-In Podcast hosts debate why AI is causing major stock market declines across traditional industries like pharmaceuticals and consumer goods. Chamath Palihapitiya explains that the market has shifted from debating "when" AI will disrupt business cash flows to "if" these companies will survive at all, forcing investors to demand massive valuations discounts as a margin of safety against existential business risk.

Key takeaways
  • The market has shifted from a "when" conversation about AI disruption timing to an "if" conversation about whether traditional business models remain viable at all.
  • Investors are demanding massive margin of safety by slashing price-to-earnings multiples in half or more (from 40x to 20x, 20x to 10x) across affected sectors.
  • Companies now face dramatically higher weighted average cost of capital (WACC) as investors demand additional risk premiums; rates are climbing from 6% to 12-13% to compensate for AI-driven uncertainty.
  • Revenue multiples are being compressed across the board (from 10x down to 3x) as the market prices in fundamental uncertainty about cash flow durability for traditional enterprises.
  • This valuation reset reflects event risk that markets cannot easily quantify—the possibility that a breakthrough AI model could obsolete entire industries without warning.

Mentioned (2)

Coca-Cola
Coca-Cola "So when will Coca-Cola's cash flows be impacted?" ▶ 0:22
Eli Lilly
Eli Lilly "When will Eli Lilly's cash flows be impacted?" ▶ 0:25